AEON Biopharma, Inc.
AEON
$0.88
$0.00-0.23%
AMEX
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 49.68% | -28.39% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 74.10% | -32.21% | |||
| Operating Income | -74.10% | 32.21% | |||
| Income Before Tax | -718.36% | 31.68% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -718.36% | 31.68% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -718.36% | 31.68% | |||
| EBIT | -74.10% | 32.21% | |||
| EBITDA | -74.54% | 32.33% | |||
| EPS Basic | -638.64% | 34.88% | |||
| Normalized Basic EPS | -458.77% | 38.12% | |||
| EPS Diluted | -638.64% | 35.00% | |||
| Normalized Diluted EPS | -458.77% | 38.12% | |||
| Average Basic Shares Outstanding | 10.80% | 4.91% | |||
| Average Diluted Shares Outstanding | 10.80% | 4.91% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||